Featured Insights
December 31, 2025
Client Alert
The law, enacted on December 18, 2025, restricts US federal procurement and grants involving biotechnology products or services provided by “biotechnology companies of concern.”
December 31, 2025
Client Alert
Implications for government entities, state-funded organizations, and stakeholders managing public revenues.
December 30, 2025
Newsletter
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law.